Minimum 15 minutes delayed. Source:
Company Overview
Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company committed to developing transformational precision medicines for patients living with rare neuroendocrine diseases. The Company develops medicines for previously untreatable or undertreated diseases and provides meaningful support for healthcare providers and patients and their families. In addition to commercializing it’s lead asset in North America, Europe and other regions, Rhythm is advancing a broad clinical development program for setmelanotide in rare MC4R pathway diseases, as well as investigational MC4R agonists LB54640 and RM-718, and a preclinical suite of small molecules for the treatment of congenital hyperinsulinism.
Email Alerts Sign-up
Founded
Delaware, November 2008
Headquarters
222 Berkeley Street, 12th Floor
Boston, MA 02116
CUSIP number
76243J105
Transfer Agent
Computershare Trust Company, Inc.
250 Royall Street
Canton, MA 02021
www.computershare.com
US Phone: +1-800-962-4284
International Phone: + 1-781-575-3120